Keyphrases
Rheumatic Diseases
100%
Maternal Outcomes
100%
Neonatal Outcome
100%
Hydroxychloroquine
100%
Disease Implications
100%
Systemic Lupus Erythematosus
40%
Disease Activity
30%
Drug Levels
30%
During Pregnancy
10%
Pregnant Women
10%
Preterm Birth
10%
Prematurity
10%
Serum Samples
10%
Non-associated
10%
Systemic Lupus Erythematosus Patient
10%
Physiological Changes
10%
Continuous Outcomes
10%
T-test
10%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
10%
Single Center
10%
Physician Global Assessment
10%
Disease Flare
10%
Drug Treatment Outcomes
10%
Fisher's Exact Test
10%
Kruskal-Wallis Test
10%
Linear Regression Model
10%
Wilcoxon Signed-rank Test
10%
Trimester
10%
Assessment Score
10%
Categorical Outcome
10%
Therapeutic Failure
10%
Non-systemic
10%
Non-therapeutic
10%
Medicine and Dentistry
Rheumatic Disease
100%
Hydroxychloroquine
100%
Systemic Lupus Erythematosus
50%
Disease Activity
30%
Premature Labor
10%
Disease Exacerbation
10%
Observational Study
10%
Analysis of Variance
10%
Linear Regression Analysis
10%
Student T Test
10%
Fisher Exact Test
10%
Prematurity
10%
Wilcoxon Signed Ranks Test
10%
Kruskal Wallis Test
10%
High Performance Liquid Chromatography-Mass Spectrometry
10%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatic Disease
100%
Hydroxychloroquine
100%
Systemic Lupus Erythematosus
50%
Disease Activity
30%
Observational Study
10%
High Performance Liquid Chromatography
10%
Prematurity
10%
Disease Exacerbation
10%
Premature Labor
10%
Immunology and Microbiology
Rheumatic Disease
100%
Hydroxychloroquine
100%
Systemic Lupus Erythematosus
50%
Drug Concentration
30%
High Performance Liquid Chromatography-Mass Spectrometry
10%